fashion -WSS

fashion

author：knowledge 2025-09-07 11:16:33 - browse：7287

Two people run on the sugar-phosphate backbone of DNA while holding base pairs — in the lab coverage from STAT — Adobe

LONDON — Widespread genetic testing as well as the development of cutting-edge, customized genetic therapies have opened the door to treating many more inherited conditions than previously possible. A few recent cases, in which bespoke medicines were created for children with exceedingly rare mutations, have raised hopes for furthering the approach.

Now, researchers and government agencies in the U.K. are trying to figure out the nitty-gritty to replicate those early one-off successes for as many patients as possible — what sort of preclinical testing a tailor-made treatment needs to go through before being used, what regulatory thresholds each treatment needs to clear, and how to pay for these therapies.

“A lot of the barriers are no longer scientific — we can make these drugs,” said Matthew Wood, a professor of pediatrics at the University of Oxford. “It’s more about, can we make them at a cost that is reasonable enough? And can we get the regulators to reduce the barriers to doing this so that when a patient shows up, you can actually make a drug quickly enough to benefit that patient, rather than it costing huge amounts of money and taking two or three years to do it?”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Test for long Covid? Researchers find new clue in blood samples

WSS

eGenesis tests gene

EU regulator recommends expanding Mounjaro approval to obesity

Medicare Advantage today, explained in one chart

Think you might have Covid

An Ebola outbreak presents a new mystery involving children

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

hotspot

fashion

focus

Drug repurposing or repositioning? The language matters

Research misconduct: Proposed new rules face resistance

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Ohioans vote in high

Supreme Court strikes down use of affirmative action

More regulation could be coming for drug ads

The cancer drug shortage isn’t new — and neither are the solutions

Lessons Learned: This is why you network to find that industry job you want

As demand for Covid shots wanes, Moderna seeks its next success

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

focus

Lessons Learned: This is why you network to find that industry job you want

Test for long Covid? Researchers find new clue in blood samples

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

Biotech venture capitalists face new demands from investors

Medicare Advantage today, explained in one chart

Medicare Advantage today, explained in one chart

entertainment

entertainment

Wikipedia

explore